Tsukuda M
Department of Otolaryngology, Yokohama City University School of Medicine, Japan.
Gan To Kagaku Ryoho. 1998 Sep;25(11):1657-64.
Histopathologically, about 90% of head and neck cancer is squamous cell carcinoma. The curative treatments for head and neck cancer are conventional radiotherapy and/or surgical resection. Multidisciplinary treatment, including combinations of the curative therapy, chemotherapy and immunotherapy, has been applied for advanced head and neck carcinomas with poor outcomes. Nowadays, chemotherapy is under investigation in the neo-adjuvant, adjuvant and concurrent chemoradiotherapy. In this paper, the treatment approach was reviewed in terms of prognostic factors which have been retrospectively estimated, along with recent developments in treatment modalities of advanced cases.
组织病理学上,约90%的头颈癌为鳞状细胞癌。头颈癌的根治性治疗方法是传统放疗和/或手术切除。包括根治性治疗、化疗和免疫治疗联合的多学科治疗已应用于预后较差的晚期头颈癌。如今,化疗正在新辅助、辅助和同步放化疗中进行研究。本文根据回顾性评估的预后因素以及晚期病例治疗方式的最新进展,对头颈癌的治疗方法进行了综述。